Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Hereditary Autoinflammatory Diseases
- A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF)
- Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
- Lanadelumab in FXII-associated Cold Autoinflammatory Syndrome (FACAS)
- Tocilizumab for the Treatment of Familial Mediterranean Fever
- The Comparison of the Efficacy of Once and Twice Daily Colchicine Dosage in Pediatric Patients With FMF
- A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies
- Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers
- Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA)
- Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever
- Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS).
- Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF)
- Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever
- Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients
- Rilonacept for Treatment of Familial Mediterranean Fever (FMF)
- Interleukin-1 Trap to Treat Autoinflammatory Diseases